Skip to main content

Akute Höhenkrankheit (AMS)

  • Chapter
  • First Online:
Book cover Alpin- und Höhenmedizin
  • 5100 Accesses

Zusammenfassung

In diesem Kapitel über die akute Höhenkrankheit (AMS) soll versucht werden, praxisrelevante und allgemeinverständliche Handlungsempfehlungen zu vermitteln, die eine deutliche Risikoreduktion und einen beschwerdefreien Aufstieg in große und extreme Höhen erlauben. Gerade in unserer modernen Leistungsgesellschaft, in der offensichtlich der schnelle Erfolg allzu häufig unser Handeln bestimmt, und umgekehrt Freizeit zum kostbaren Gut erklärt wird, geraten wir beim Höhenbergsteigen in einen nahezu unlösbaren Interessenskonflikt. Darüber soll in den folgenden Abschnitten auch durchaus kontrovers berichtet werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Ayus JC, Moritz ML (2008) Exercise-associated hyponatremia masqerading as acute mountain sickness: are we missing the diagnosis? Clin J Sport Med 18: 383–386

    Article  PubMed  Google Scholar 

  • Bailey DM, Bärtsch P, Knauth M, Baumartner RW (2009a) Emerging concepts in acute mountain sickness and high altittude cerebral edema: form the molecular to the morphological. Cell Mol Life Sci 66: 3583–3594

    Google Scholar 

  • Bailey DM, Taudorf S, Berg RM et al. (2009b) Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness? Am J Physiol Regul Integr Comp Physiol 297: R 1238–1292

    Google Scholar 

  • Basnyat B, Lemaster J, Litch JA (1999) Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243m in the Himalayas. Aviat Space Environ Med 70: 867–873

    CAS  PubMed  Google Scholar 

  • Basnyat B, Gertsch JH, Holck PS et al. (2006) Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the pevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy trial. High Alt Med Biol 7: 17–27

    Article  CAS  PubMed  Google Scholar 

  • Bloch KE, Turk AJ, Maggiorini M et al. (2009) Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Al Med Biol 10: 25–32

    Article  Google Scholar 

  • Davies AJ, Kalson NS, Stokes S et al. (2009) Determinants of summiting success and acute mountain sickness on Mt Kilimajaro 5895 m. Wilderness Environ Med 20: 311–317

    Article  PubMed  Google Scholar 

  • De Acosta I (1590) Historia Natural y Moral de las Indias, Lib 3, Cap. 9, luan de Leon, Seville

    Google Scholar 

  • Dumont L, Mardirosoff C, Tramer MR (2000) Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 321, S 267–272

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ellsworth AJ, Meyer EF, Larson EB (1991) Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West. J Med 154: 289–293

    CAS  Google Scholar 

  • Ferrazzini G, Maggiorini M, Friemler S et al. (1987) Successful treatment of acute mountain sickness with dexamethasone. BMJ 294: 1380–1382

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fitch RF (1964) Mountain sickness: a cerebral form. Ann. Intern. Med. 60: 871–876

    Article  CAS  PubMed  Google Scholar 

  • Hackett PH, Roach RC, Wood RA et al. (1988) Dexamethasone for prevention and treatment of acute montain sickness. Aviat Space Environ Med 59: 950–954

    CAS  PubMed  Google Scholar 

  • Hackett PH, Roach RC (2001) Current concepts: high-altitude Illness. N Engl J Med 345: 107–114

    Article  CAS  PubMed  Google Scholar 

  • Hackett PH, Rennie D (1979) Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. Am J Med 67: 214–218

    Article  CAS  PubMed  Google Scholar 

  • Houston, CS. (1960) Acute pulmonary edema of high altitude. N Engl J Med 263: 478–80

    Article  CAS  PubMed  Google Scholar 

  • Houston, CS, Dickinson J (1975) Cerebral form of high-altitude illness. Lancet 2: 758–761

    Article  CAS  PubMed  Google Scholar 

  • Hultgren H, Spickard W (1960) Medical experiences in Peru. Stanford Med Bull 18: 97–98

    Google Scholar 

  • Kallenberg K, Bailey FM, Christ S et al. (2007) Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab 27: 1064–1071

    PubMed  Google Scholar 

  • Kalson NS, Thompson J, Davie AJ et al. (2009) The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro 5895m. Eur J Appl Physiol 105: 373–379

    Article  CAS  PubMed  Google Scholar 

  • Karinen H, Peltonen J, Tikkanen H (2008) Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: an ovservational study. High Alt Med Biol 9: 301–306

    Article  PubMed  Google Scholar 

  • Kayser B, Dumont L, Lysakowski C et al. (2012) Reappraisal of acetazolamide for the prevention of acute mountain sickness: A systematic review and meta-analysis. High Alt Med Biol 13: 82–92

    Article  CAS  PubMed  Google Scholar 

  • Kim JW, Tchernyshyov I, Semenza GL et al. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177–185

    Article  PubMed  Google Scholar 

  • Levine BD, Yoshimura K, Kobayashi T et al. (1989) Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 321: 1707–1713

    Article  CAS  PubMed  Google Scholar 

  • Luks AM, Swenson ER (2008) Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest 133: 744–755

    Article  PubMed  Google Scholar 

  • Luks AM, McIntosh SE, Grissom CK et al. (2010) Wilderness Medical Society consensus guidelines fort he prevention and treatment of acute altitude Illness. Wilderness Environ. Med 21: 146–155

    Google Scholar 

  • Maggiorini M, Muller A, Hofstetter D et al. (1998) Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat. Space Environ Med 69: 1186–1192

    CAS  Google Scholar 

  • Murdoch DR (1999) How fast is too fast? Attempts to define a recommended ascent rate to prevent acute mountain sickness. ISMM Newsletter 9: 3–6

    Google Scholar 

  • Pesce C, Leal C, Pinto H et al. (2005) Determinants of acute mountain sickness and success on Mount Aconcagua 6962 m. High Al Med Biol 6: 158–166

    Article  Google Scholar 

  • Ravenhill TH (1913) Some experience of mountain sickness in the Andes. J Trop Med Hyg 16: 313–320

    Google Scholar 

  • Richalet JP, Larmignat P, Poitrine E et al. (2011) Physiological risk factors of severe high altitude illness: a prospective cohort study. Am J Respir Crit Care Med 185: 192–198

    Article  PubMed  Google Scholar 

  • Richardson A, Wat P, Maxwell N (2009) Hydration and the physiological responses to acute normobaric hypoxia. Wilderness Environ. Med 20: 212–220

    Google Scholar 

  • Roach RC, Bärtsch P, Hackett PH, Oelz O (1993) The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G (Hrsg) Hypoxia and mountain medicine. Queen City Printers, Burlington, VT, S 272–274

    Google Scholar 

  • Roach RC, Maes D, Sandoval D et al. (2000) Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 88: 581–585

    CAS  PubMed  Google Scholar 

  • Schneider M, Bernasch D, Weymann J et al. (2002) Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci. Sports Exerc 34: 1886–1891

    Article  PubMed  Google Scholar 

  • Schoonmann GG, Sandor PS, Nirkko AC et al. (2008) Hypoxia-induced acute mountain sickness is associated with intracelllular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 28: 198–206

    Article  Google Scholar 

  • Silber E, Sonnenberg P, Collier DJ et al. (2003) Clinical features of headache at altitude: a prospective study. Neurology 60: 1167–1171

    Article  CAS  PubMed  Google Scholar 

  • Swenson ER, Teppema LJ (2007) Prevention of acute mountain sickness by acetazolamide: as yet an unfinished sotroy. J Appl Physiol 102: 1305–1307

    Article  PubMed  Google Scholar 

  • Van Osta A, Moraine JJ, Melot C et al. (2005) Effects of high altitude exposure on cerebral hemodynamics in normal subjects. In: Stroke 36, S 557–560

    Article  PubMed  Google Scholar 

  • Wang P, Koehle MS, Rupert JL (2010) No association between alleles of the bradykinin receptor-B2 gene and acute mountain sickness. Exp Biol Med 235: 737–740

    Article  CAS  Google Scholar 

  • West JB, Lahiri S, Gill MB et al. (1962) Arterial oxygen saturation during exercise at high altitude. J Appl Physiol.17: 617–621

    CAS  PubMed  Google Scholar 

  • West JB (1996) T.H. Ravenhill and his contributions to mountain sickness. J Appl Physiol 80: 715–724

    CAS  PubMed  Google Scholar 

  • West JB (1998) High Life: A history of high-altitude physiology and medicine. Oxford University Press, New York

    Book  Google Scholar 

  • West JB (2004) The physiologic basis of high-altitude disease. Ann Intern Med 141: 789–800

    Article  PubMed  Google Scholar 

  • West JB (2011) Con: Headache should not be a required symptom fort he diagnosis of acute mountain sickness. High Alt Med Biol 12: 23–25; discussion 27

    Article  PubMed  Google Scholar 

  • Wilson DF, Roy A, Lahiri S (2005) Immediate and long-term responses of the carotid body to high altitude. High Alt Med Biol 6: 97–111

    Article  PubMed Central  PubMed  Google Scholar 

  • Wu TY, Ding SQ, Liu JL et al. (2009) Reduced incidence and severity of acute mountain sickness in Qinghai-Tibet railroad construction workers ater repeated 7-month exposures despite 5-month low altitude periods. High Alt Med Biol 10: 221–232

    Article  PubMed  Google Scholar 

  • Wu TY, Ding SQ, Zhang SL et al. (2010) Altitude illness in Qinghai-Tibet railroad passengers. High Alt Med Biol 11: 189–198

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang Schaffert .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Wien

About this chapter

Cite this chapter

Schaffert, W. (2015). Akute Höhenkrankheit (AMS). In: Berghold, F., et al. Alpin- und Höhenmedizin. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1833-7_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1833-7_42

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1832-0

  • Online ISBN: 978-3-7091-1833-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics